PCA treatments - presentation
This presentation was given to the PCA Support Group at our meeting on 3 February 2012.
I thought it clearly showed the challenges of getting a drug to market and also highlighted for me why pharmaceutical companies don't want to invest in therapies for dementia: without a clear line of sight for the impact on the bottom line, there just is no incentive for them to do so.
Anyway, feel free to have a flick through and let me know what you think: